,trastuzumab deruxtecan
astrazeneca,daiichi sankyo
['breast', 'enhertu']
asco: astrazeneca, daiichi's enhertu could transform breast cancer treatment with landmark her2-low show - fiercepharma #strategy #competitiveintelligence #marketing #pharmaceutical #competitivemarketing #healthcare #pharma #biotech 
Strategy & Competitive Marketing | Digital & Social Pharma | Life Sciences Investment | Cell & Gene Therapy | Vaccines